Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141362 |
| CAS No | NA |
| Mol.F. | C22H19F3N2O |
| Mol.Wt. | 384.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141363 |
| CAS No | NA |
| Mol.F. | C22H19F3N2O |
| Mol.Wt. | 384.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141364 |
| CAS No | NA |
| Mol.F. | C26H27N5O4 |
| Mol.Wt. | 473.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141365 |
| CAS No | NA |
| Mol.F. | C20H26N2O2 |
| Mol.Wt. | 326.44 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141366 |
| CAS No | 2680528-95-2 |
| Mol.F. | C19H24N2O2 |
| Mol.Wt. | 312.41 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141368 |
| CAS No | NA |
| Mol.F. | C8H22N6O |
| Mol.Wt. | 218.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141369 |
| CAS No | NA |
| Mol.F. | C8H21N7O2 |
| Mol.Wt. | 247.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141370 |
| CAS No | NA |
| Mol.F. | C8H21N7O2 |
| Mol.Wt. | 247.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141371 |
| CAS No | NA |
| Mol.F. | C8H20N8O3 |
| Mol.Wt. | 276.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141372 |
| CAS No | NA |
| Mol.F. | C13H17Br2N3O2 |
| Mol.Wt. | 407.1 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141373 |
| CAS No | NA |
| Mol.F. | C9H8Cl2N4O |
| Mol.Wt. | 259.1 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141374 |
| CAS No | NA |
| Mol.F. | C5H7N3O3 |
| Mol.Wt. | 157.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141375 |
| CAS No | NA |
| Mol.F. | C11H10Cl2N4O2 |
| Mol.Wt. | 301.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141376 |
| CAS No | NA |
| Mol.F. | C18H18Cl2N2O5 |
| Mol.Wt. | 413.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141377 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O5 |
| Mol.Wt. | 399.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141378 |
| CAS No | NA |
| Mol.F. | C19H20Cl2N2O5 |
| Mol.Wt. | 427.3 |
| INV STATUS | CUSTOM SYNTHESIS |